Search for: "Gilead Sciences Inc." Results 141 - 160 of 182
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Sep 2022, 2:13 am by Neil Wilkof
Notably, Article 1360 had never been applied in practice since 2006, the year of enactment of Part IV of the Civil Code covering IP rights.Interestingly, several months before this amendment, the Government issued an order allowing a Russian legal entity, “Pharmasyntez”, to use Remdesivir, an antiviral medication used for treatment of Covid-19, without authorization of the patent owner, Gilead Sciences, Inc. [read post]
8 Mar 2020, 7:53 pm by David Jensen
 Or Gilead Sciences, Inc., the new owner of Forty Seven, could convert the CIRM grant to a loan, which then could be paid off with interest, ending the possibility of extended royalties from the company. [read post]
12 May 2015, 3:30 pm by James Galvin
Steel Corp. 90271J598 UBS Trigger Phoenix Autocallable Optimization Securities linked to United Rentals, Inc. 90271J523 UBS Trigger Phoenix Autocallable Optimization Securities linked to MGM Resorts International 90271J556 UBS Trigger Phoenix Autocallable Optimization Securities linked to Market Vectors Gold Miners ETF 90271J531 UBS Trigger Phoenix Autocallable Optimization Securities linked to Gilead Sciences Inc. 90271J549 UBS Trigger Phoenix Autocallable… [read post]
17 Mar 2021, 4:00 am by Alan Macek
Gilead Sciences Canada, Inc., 2020 FC 486. [read post]
19 Dec 2008, 1:00 pm
(IP Kenya) UK: Damages for observing patent injunction: Les Laboratoires Servier & Anor v Apotex Inc & Ors (IP finance) US/China: ‘Eli Lilly lobbies on counterfeiting and regulatory issues involving China’ (IP Dragon) US: Federal judge dismisses patent lawsuit filed by Human Genome Sciences against Genentech over patent related to type of protein that can be used to detect tumours (Law360) US: MedImmune seeks invalidation of five patents owned by… [read post]
23 Sep 2014, 1:25 pm by Dennis Crouch
 The first situation (PTA) was a focus of Gilead Sciences v. [read post]
12 Jun 2024, 9:40 am by Dennis Crouch
Excavator Co., 290 U.S. 240 (1933); see also Gilead Scis., Inc. v. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
8 Jan 2016, 5:26 am
’ In re Gilead Sciences Securities Litigation, 536 F.3d 1049 (U.S. [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech)   Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
20 Apr 2009, 7:07 am
  The issue was the theory to be used  for judging “loss causation” in securities transactions; the case was Gilead Sciences, et al., v. [read post]
14 Sep 2021, 4:00 am by Alan Macek
Gilead Sciences Canada, Inc., 2021 FCA 122, the Federal Court of Appeal considered when summary determination is appropriate, particularly when a responding party has moved to quash the motion for summary trial. [read post]
26 Jun 2015, 12:30 am
 Actually, Mr Justice Arnold had himself moved away from the idea already - he distinguished his decision in the later case of Idenix Pharmaceutical, Inc v Gilead Sciences, Inc (reported by IPKat here) in which he declined to construe a claim narrowly on the basis of the prosecution history.This did not however have any effect on the outcome - Floyd LJ otherwise endorsed Arnold J's application of the Protocol questions to likewise find that there was no… [read post]